DrugPatentWatch Database Preview
Mylan Pharms Inc Company Profile
What is the competitive landscape for MYLAN PHARMS INC, and what generic and branded alternatives to MYLAN PHARMS INC drugs are available?
MYLAN PHARMS INC has one hundred and sixteen approved drugs.
There are twenty-one tentative approvals on MYLAN PHARMS INC drugs.
Summary for Mylan Pharms Inc
| US Patents: | 0 |
| Tradenames: | 103 |
| Ingredients: | 101 |
| NDAs: | 116 |
Drugs and US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | ESZOPICLONE | eszopiclone | TABLET;ORAL | 091151-001 | Mar 26, 2013 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | FLURAZEPAM HYDROCHLORIDE | flurazepam hydrochloride | CAPSULE;ORAL | 070345-002 | Nov 27, 1985 | RX | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | RAMIPRIL | ramipril | TABLET;ORAL | 090650-003 | Jun 30, 2011 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | DOXEPIN HYDROCHLORIDE | doxepin hydrochloride | CAPSULE;ORAL | 070791-001 | May 13, 1986 | AB | RX | No | No | Start Trial | Start Trial | ||||
| Mylan Pharms Inc | CITALOPRAM HYDROBROMIDE | citalopram hydrobromide | TABLET;ORAL | 077037-002 | Nov 5, 2004 | DISCN | No | No | Start Trial | Start Trial | |||||
| Mylan Pharms Inc | HYDROCHLOROTHIAZIDE | hydrochlorothiazide | TABLET;ORAL | 040735-002 | Jan 23, 2007 | AB | RX | No | No | Start Trial | Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Mylan Pharms Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 4,971,800 | Start Trial |
| Mylan Pharms Inc | MAXZIDE-25 | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-003 | May 13, 1988 | 4,444,769 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,105,783 | Start Trial |
| Mylan Pharms Inc | AVITA | tretinoin | CREAM;TOPICAL | 020404-003 | Jan 14, 1997 | 5,045,317 | Start Trial |
| Mylan Pharms Inc | MAXZIDE | hydrochlorothiazide; triamterene | TABLET;ORAL | 019129-001 | Oct 22, 1984 | 4,444,769 | Start Trial |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
